HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors
A. Gabrielle J. van der Kraan(Monash Medical Centre), Julian M.W. Quinn(Cancer Institute of New South Wales), Matthew T. Gillespie(Hudson Institute of Medical Research), Jiake Xu(Shenzhen Institutes of Advanced Technology), Preetinder P. Singh, Ryan C. Chai(Garvan Institute of Medical Research), Benjamin Lang(Beth Israel Deaconess Medical Center), John T. Price(The University of Melbourne)
Cited by 63
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536
Heart disease prediction using supervised machine learning algorithms: Performance analysis and comparison
|Computers in Biology and Medicine|2021|482